Lyra Therapeutics (LYRA) PT Raised to $26 at BofA Securities

December 7, 2020 12:26 PM EST
Get Alerts LYRA Hot Sheet
Price: $8.08 -2.88%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 11 | New: 50
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

BofA Securities raised its price target on Lyra Therapeutics (NASDAQ: LYRA) to $26.00 (from $19.00) while maintaining a Neutral rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change